Clinical Trial

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

Study acronym: IPD
Recruiting
View on ClinicalTrials.gov →
Summary
After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-12-07; most recent amendment 2026-04-23.
Trial Details
NCT Number NCT04664556
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: Pfizer
Conditions Pneumococcal Infections, Pneumococcal Conjugate Vaccine, Antibiotic Treatment, Mortality
Enrollment 2,500 participants
Start Date 2010-12-13
Primary Completion 2030-01-01 (estimated)
Study Completion 2030-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-28